エピソード

  • Building Better Cancer Care Through Global Collaboration
    2026/11/12

    In this episode, Dr. Dale Shepard speaks with Dom Kosmina, chief medical physicist and chief operations officer at Radiochirurgia Zagreb in Croatia, a member of the Cleveland Clinic Connected Network. They discuss how global partnerships foster knowledge sharing and quality improvement, benefiting providers, institutions and patients.

    続きを読む 一部表示
    15 分
  • Adaptive Radiation Therapy: How AI Is Personalizing Cancer Treatment
    2026/11/05

    Adaptive radiation therapy is changing how radiation is delivered. In this episode, Dr. Ehsan Balagamwala discusses how the Ethos platform uses AI-assisted planning to adjust treatment based on a patient's anatomy at the time of treatment. The conversation explores patient selection, clinical applications, workflow advantages and how adaptive planning may help further personalize radiation oncology care.

    続きを読む 一部表示
    22 分
  • Cancer Survivorship in the Era of CAR-T and Bispecific Therapies
    2026/10/29

    As cancer therapies continue to evolve, so do the long-term needs of survivors. In this episode, Dr. Dale Shepard sits down with Christina Ferraro, CNP, Director of Oncology Survivorship at Cleveland Clinic, to discuss the growing role of survivorship care in identifying and managing late and long-term toxicities. Together, they explore how newer treatments such as CAR-T and bispecific therapies are changing survivorship needs, the importance of monitoring for infections, secondary cancers and other delayed effects, and how dedicated survivorship programs help patients thrive long after treatment ends.

    続きを読む 一部表示
    21 分
  • Inhaled KB707 Plus Pembrolizumab in Lung Cancer
    2026/10/22

    Patients with advanced lung cancer often experience disease progression despite treatment with immune checkpoint inhibitors. In this episode of Cancer Advances, Wen Wee Ma, MBBS, discusses data evaluating inhaled KB707, a modified herpes simplex virus designed to locally deliver IL-2 and IL-12, in combination with pembrolizumab. Dr. Ma reviews the rationale behind this novel immunotherapy approach, early efficacy and safety findings and the potential role of inhaled therapies in future lung cancer treatment strategies.

    続きを読む 一部表示
    13 分
  • Improving Diagnosis and Care for Rare Cancers and Blood Diseases
    2026/10/15

    Rare cancers and blood diseases present unique diagnostic and treatment challenges, often requiring specialized expertise and multidisciplinary care. In this episode of Cancer Advances, Sudipto Mukherjee, MD, PhD, MPH, discusses how Cleveland Clinic's Rare Cancers and Blood Diseases Program is improving diagnostic accuracy, accelerating access to care and advancing research across more than 90 rare conditions. Learn how integrated pathology review, genomic insights, collaborative care models and emerging therapeutic targets are helping improve outcomes for patients with rare diseases.

    続きを読む 一部表示
    23 分
  • CAR T and Bispecific Therapies in AL Amyloidosis
    2026/10/08

    Hematologist and myeloma specialist Shahzad Raza, MD, joins the Cancer Advances podcast to discuss emerging cellular and immune therapies for AL amyloidosis. Listen as Dr. Raza reviews early data on CAR T-cell therapy and bispecific antibodies, their potential to induce deep hematologic responses and how these approaches may improve organ function and long-term outcomes for patients with this rare plasma cell disorder.

    続きを読む 一部表示
    21 分
  • Are We Missing Patients? Expanding Germline Genetic Testing in Oncology
    2026/10/01

    As recommendations for germline genetic testing continue to expand, many eligible patients remain untested. In this episode of Cancer Advances, Demitrios Dedousis, MD, discusses current testing indications, common gaps in implementation and the clinical implications of identifying hereditary cancer predisposition syndromes. Learn how germline findings can influence treatment decisions, screening protocols and risk assessment for families.

    続きを読む 一部表示
    22 分
  • Partnering with Classical Hematology: Optimizing Referrals, Diagnostics and Patient Care
    2026/09/24

    Bethany Samuelson Bannow, MD, Director of Classical Hematology at Cleveland Clinic, joins the Cancer Advances podcast to discuss how stronger collaboration between oncologists, primary care physicians and classical hematologists can improve diagnostic efficiency and patient outcomes. Listen as Dr. Samuelson Bannow shares practical referral guidance, highlights new diagnostic care pathways for common blood disorders, and explores strategies to address workforce shortages while expanding access to specialized hematology care.

    続きを読む 一部表示
    16 分